LifePoint, Inc. (LFPI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2004 | 2.45 Million USD | -58.94% |
| 2003 | 5.97 Million USD | 77.5% |
| 2002 | 3.36 Million USD | 41.72% |
| 2001 | 2.37 Million USD | 162.04% |
| 2000 | 906.72 Thousand USD | 43.99% |
| 1999 | 629.72 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2005 Q2 | 1.59 Million USD | -25.61% |
| 2005 Q3 | 1.59 Million USD | -0.18% |
| 2005 Q1 | 2.14 Million USD | -12.62% |
| 2004 FY | 2.45 Million USD | -58.94% |
| 2004 Q2 | 3.11 Million USD | -60.16% |
| 2004 Q1 | 7.82 Million USD | 30.98% |
| 2004 Q3 | 2.12 Million USD | -31.77% |
| 2004 Q4 | 2.45 Million USD | 15.32% |
| 2003 Q2 | 3.25 Million USD | -6.69% |
| 2003 Q3 | 5.29 Million USD | 62.81% |
| 2003 FY | 5.97 Million USD | 77.5% |
| 2003 Q1 | 3.48 Million USD | 3.52% |
| 2003 Q4 | 5.97 Million USD | 12.87% |
| 2002 Q4 | 3.36 Million USD | -60.19% |
| 2002 FY | 3.36 Million USD | 41.72% |
| 2002 Q3 | 8.45 Million USD | -5.76% |
| 2002 Q2 | 8.97 Million USD | 17.3% |
| 2002 Q1 | 7.65 Million USD | 222.04% |
| 2001 Q3 | 2.08 Million USD | 184.94% |
| 2001 Q1 | 692.44 Thousand USD | -23.63% |
| 2001 Q4 | 2.37 Million USD | 14.21% |
| 2001 Q2 | 730.12 Thousand USD | 5.44% |
| 2001 FY | 2.37 Million USD | 162.04% |
| 2000 Q3 | 760.82 Thousand USD | 12.44% |
| 2000 Q4 | 906.72 Thousand USD | 19.18% |
| 2000 FY | 906.72 Thousand USD | 43.99% |
| 2000 Q1 | 643.08 Thousand USD | 0.0% |
| 2000 Q2 | 676.66 Thousand USD | 5.22% |
| 1999 FY | 629.72 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -4.44% |
| Ansell Limited | 1.32 Billion USD | 99.815% |
| Ansell Limited | 1.33 Billion USD | 99.816% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | 98.057% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -160.204% |
| Psykey, Inc. | 2.47 Million USD | 0.802% |
| ConvaTec Group Plc | 2.01 Billion USD | 99.878% |
| ConvaTec Group Plc | 2.02 Billion USD | 99.879% |
| Encision Inc. | 1.98 Million USD | -23.7% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | 19.283% |
| Innovative MedTech Inc. | 6.13 Million USD | 59.996% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | 75.895% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | 27.819% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | 19.279% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -216.125% |
| SmileDirectClub, Inc. | 982.26 Million USD | 99.75% |
| Sector 10, Inc. | 9.84 Million USD | 75.073% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 99.819% |
| SheerVision, Inc. | 1.43 Million USD | -71.452% |
| United Health Products, Inc. | 1.99 Million USD | -22.778% |
| Vasamed, Inc. | 1 Million USD | -144.123% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | 35.421% |
| Yubo International Biotech Limited | 2.91 Million USD | 15.778% |